Published in Pediatr Pulmonol on November 01, 1998
Pulmonary neuroendocrine cells, airway innervation, and smooth muscle are altered in Cftr null mice. Am J Respir Cell Mol Biol (2006) 1.04
Postnatal Infections and Immunology Affecting Chronic Lung Disease of Prematurity. Clin Perinatol (2015) 0.77
Oxygen, gastrin-releasing Peptide, and pediatric lung disease: life in the balance. Front Pediatr (2014) 0.76
Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U S A (1998) 3.85
Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest (1998) 3.78
Acute immunologic pulmonary alveolitis. J Clin Invest (1974) 3.53
Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J Clin Invest (1982) 3.49
AXOR12, a novel human G protein-coupled receptor, activated by the peptide KiSS-1. J Biol Chem (2001) 3.32
Plasma fibronectin supports neuronal survival and reduces brain injury following transient focal cerebral ischemia but is not essential for skin-wound healing and hemostasis. Nat Med (2001) 3.01
Brief report: idiopathic diffuse hyperplasia of pulmonary neuroendocrine cells and airways disease. N Engl J Med (1992) 2.91
High Altitude Flatus Expulsion (HAFE). West J Med (1981) 2.72
Synergistic and additive killing by antimicrobial factors found in human airway surface liquid. Am J Physiol Lung Cell Mol Physiol (2000) 2.55
Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem (2001) 2.50
A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest (1995) 2.48
Role of oxygen metabolites in immune complex injury of lung. J Immunol (1981) 2.39
Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy. Chest (1998) 2.39
Peptide binding and presentation by mouse CD1. Science (1995) 2.38
Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis. J Clin Invest (1997) 2.30
Bactericidal activity of mammalian cathelicidin-derived peptides. Infect Immun (2000) 2.24
Production of beta-defensin antimicrobial peptides by the oral mucosa and salivary glands. Infect Immun (1999) 2.19
Adequacy of hormone replacement therapy for osteoporosis prevention assessed by serum oestradiol measurement, and the degree of association with menopausal symptoms. Br J Gen Pract (1997) 2.16
In vivo damage of rat lungs by oxygen metabolites. J Clin Invest (1981) 2.10
Altered fluid transport across airway epithelium in cystic fibrosis. Science (1993) 2.09
Discovery of new human beta-defensins using a genomics-based approach. Gene (2001) 2.08
Cloning, expression, and tissue distribution of a human amiloride-sensitive Na+ channel. Am J Physiol (1994) 2.07
Images in clinical medicine. Superior vena cava syndrome. N Engl J Med (1993) 2.06
Polarity influences the efficiency of recombinant adenoassociated virus infection in differentiated airway epithelia. Hum Gene Ther (1998) 2.00
An indicator to aid management in assigning program priorities. Public Health Rep (1970) 2.00
Structure and mapping of the human beta-defensin HBD-2 gene and its expression at sites of inflammation. Gene (1998) 1.99
Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer. Clin Cancer Res (2000) 1.98
C5a-induced expression of P-selectin in endothelial cells. J Clin Invest (1994) 1.93
Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production. Gene Ther (2005) 1.93
Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J Clin Invest (1989) 1.86
Racial differences in colorectal cancer mortality. The importance of stage and socioeconomic status. J Clin Epidemiol (2001) 1.81
Requirement and role of C5a in acute lung inflammatory injury in rats. J Clin Invest (1996) 1.77
Normal sweat chloride values do not exclude the diagnosis of cystic fibrosis. Am J Respir Crit Care Med (1995) 1.70
Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J Clin Invest (1993) 1.64
Pulmonary aspergillosis: an analysis of 41 patients. Ann Thorac Surg (1976) 1.62
Producing and avoiding stress shielding. Laboratory and clinical observations of noncemented total hip arthroplasty. Clin Orthop Relat Res (1992) 1.58
Variation in attractiveness of human subjects to malaria mosquitoes (Diptera: Culicidae) in The Gambia. J Med Entomol (1993) 1.58
Isolation from human serum of an inactivator of bacterial lipopolysaccharide. Am J Pathol (1977) 1.58
Regional localization of chromosome 3-specific DNA fragments by using a hybrid cell deletion mapping panel. Am J Hum Genet (1988) 1.58
Phlebotomy overdraw in the neonatal intensive care nursery. Pediatrics (2000) 1.57
Pyrethroid-treated bednet effects on mosquitoes of the Anopheles gambiae complex in The Gambia. Med Vet Entomol (1991) 1.55
Endothelial cell killing by neutrophils. Synergistic interaction of oxygen products and proteases. Am J Pathol (1989) 1.55
The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr (1998) 1.53
Transient surfactant protein B deficiency in a term infant with severe respiratory failure. J Pediatr (1998) 1.53
Disruption of the beta subunit of the epithelial Na+ channel in mice: hyperkalemia and neonatal death associated with a pseudohypoaldosteronism phenotype. Proc Natl Acad Sci U S A (1999) 1.53
Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma. J Immunol (2001) 1.52
Surgical correction of hypotropias associated with thyroid dysfunction. Arch Ophthalmol (1965) 1.51
Suppression by superoxide dismutase of immune-complex--induced pulmonary alveolitis and dermal inflammation. Am J Pathol (1981) 1.50
Requirements for leukocyte adhesion molecules in nephrotoxic nephritis. J Clin Invest (1993) 1.49
Feline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defect. J Clin Invest (1999) 1.46
Influence of cell polarity on retrovirus-mediated gene transfer to differentiated human airway epithelia. J Virol (1998) 1.46
In vitro and in vivo stimulation of rat neutrophils and alveolar macrophages by immune complexes. Production of O-2 and H2O2. Am J Pathol (1983) 1.46
Fluorescence versus white-light bronchoscopy for detection of preneoplastic lesions: a randomized study. J Natl Cancer Inst (2001) 1.45
Mechanism of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo. J Immunol (1995) 1.45
Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis. Ann Surg (1989) 1.43
Oxygen radical dependent lung damage following thermal injury of rat skin. J Trauma (1983) 1.41
Quantitative morphometry of renal biopsies prior to cyclosporine in nephrotic syndrome. Pediatr Nephrol (1998) 1.41
Integrase-defective lentiviral vectors: progress and applications. Gene Ther (2009) 1.41
Evidence for the role of oxygen radicals in acute nephrotoxic nephritis. Lab Invest (1984) 1.40
An association study of 43 SNPs in 16 candidate genes with atorvastatin response. Pharmacogenomics J (2005) 1.39
Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol (1994) 1.39
Serum paraoxonase (PON1) 55 and 192 polymorphism and paraoxonase activity and concentration in non-insulin dependent diabetes mellitus. Atherosclerosis (1998) 1.36
Can anything be done to maintain the effectiveness of pyrethroid-impregnated bednets against malaria vectors? Philos Trans R Soc Lond B Biol Sci (1998) 1.36
Characterization of matrix metalloproteinases produced by rat alveolar macrophages. Am J Respir Cell Mol Biol (1999) 1.36
Progression of somatic CTG repeat length heterogeneity in the blood cells of myotonic dystrophy patients. Hum Mol Genet (1998) 1.36
Suppression of immune complex-induced inflammation by the chemotactic factor inactivator. J Clin Invest (1977) 1.33
Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy. Hum Mol Genet (1999) 1.32
Encephalocraniocutaneous lipomatosis. Pediatrics (1978) 1.32
The requirement for serum complement in the detoxification of bacterial endotoxin. J Immunol (1972) 1.30
Protein degradation following treatment with hydrogen peroxide. Am J Pathol (1984) 1.30
Acute lung injury in rat caused by immunoglobulin A immune complexes. J Clin Invest (1984) 1.29
Acute acid aspiration lung injury in the rat: biphasic pathogenesis. Anesth Analg (1989) 1.27
A superfamily of S locus-related sequences in Arabidopsis: diverse structures and expression patterns. Plant Cell (1994) 1.27
Role of stromelysin 1 and gelatinase B in experimental acute lung injury. Am J Respir Cell Mol Biol (2001) 1.25
Immune complex vasculitis with secondary ulcerative dermatitis in aged C57BL/6NNia mice. Vet Pathol (1994) 1.25
The role of neutrophils, oxidants, and proteases in the pathogenesis of acid pulmonary injury. Anesthesiology (1992) 1.24
A severe phenotype in mice with a duplication of exon 3 in the cystic fibrosis locus. Hum Mol Genet (1993) 1.22
The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection. Antimicrob Agents Chemother (2001) 1.22
Pancreatitis-induced acute lung injury. An ARDS model. Ann Surg (1988) 1.21
Role of oxygen radicals in phorbol myristate acetate-induced glomerular injury. Kidney Int (1985) 1.20
Glomerular inflammation induces resistance to tubular injury in the rat. A novel form of acquired, heme oxygenase-dependent resistance to renal injury. J Clin Invest (1996) 1.20
Cross-union complicating fracture of the forearm. Part I: Adults. J Bone Joint Surg Am (1987) 1.20
Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury. J Immunol (1999) 1.19
Cytopathological analysis of sputum in patients with airflow obstruction and significant smoking histories. Cancer Res (1996) 1.19
Increasing epithelial junction permeability enhances gene transfer to airway epithelia In vivo. Am J Respir Cell Mol Biol (2000) 1.18
Personal protection against mosquitoes in Dar es Salaam, Tanzania, by using a kerosene oil lamp to vaporize transfluthrin. Med Vet Entomol (2002) 1.18
Rh-related antigen CD47 is the signal-transducer integrin-associated protein. J Biol Chem (1994) 1.17
Early-onset inflammatory responses in vivo to adenoviral vectors in the presence or absence of lipopolysaccharide-induced inflammation. Am J Respir Cell Mol Biol (1999) 1.17
Human coronavirus 229E infects polarized airway epithelia from the apical surface. J Virol (2000) 1.17
Genetics and physiology of the myotonic muscle disorders. N Engl J Med (1993) 1.16
Role of O2- in neutrophil recruitment into sites of dermal and pulmonary vasculitis. Free Radic Biol Med (1990) 1.15
Increased pulmonary neuroendocrine cells with bombesin-like immunoreactivity in adult patients with eosinophilic granuloma. J Clin Invest (1990) 1.15
Congeners of SMAP29 kill ovine pathogens and induce ultrastructural damage in bacterial cells. Antimicrob Agents Chemother (2001) 1.14
A novel murine beta -defensin expressed in tongue, esophagus, and trachea. J Biol Chem (2000) 1.14
Role of matrix metalloproteinases in models of macrophage-dependent acute lung injury. Evidence for alveolar macrophage as source of proteinases. Am J Respir Cell Mol Biol (1999) 1.13
The role of tumor necrosis factor-alpha in the pathogenesis of aspiration pneumonitis in rats. Anesthesiology (1999) 1.12
Effect of glutathione peroxidase activity on lipid peroxidation in biological membranes. Biochim Biophys Acta (1976) 1.12
Subcellular distribution of tyrosine aminotransferase in rat brain. Arch Biochem Biophys (1969) 1.10
Protective function of C6 in rabbits treated with bacterial endotoxin. J Immunol (1971) 1.10
Cathelicidin peptides inhibit multiply antibiotic-resistant pathogens from patients with cystic fibrosis. Antimicrob Agents Chemother (2001) 1.10